News in early breast cancer this year was marked by updated U.S. Preventive Services Task Force (USPSTF) screening ...

Pembrolizumab in early triple-negative breast cancer shows irAEs similar to KEYNOTE ... patients received four different Keytruda-containing systemic therapy regimens: the KEYNOTE-552 regimen of ...

Mortality rates have also seen encouraging declines, with a 41% drop in the UK since the early 1970s ... could block breast cancer growth, paving the way for hormone therapy.

Opens in a new tab or window An FDA panel on Thursday endorsed a cryoablation system as an alternative to surgery for some early breast cancer ... with adjuvant endocrine therapy outweigh the ...

Mabel Mardones, MD, Rocky Mountain Cancer Centers, discusses the future of HR+/HER2– breast cancer treatment, focusing on the importance of biomarkers and the potential of SIRDs to improve patient ...

SYNC, its first homegrown CAR-T therapy, one of the first to show promise in treating certain types of brain cancers. This ...

Tiny circles called ecDNA are critical in cancer development and drug resistance. An international team publishes landmark studies detailing new findings and potential therapies.

For cancer patients who require radiation therapy, permanent tattoos have long ... The experience of breast cancer patients highlights the emotional toll these tattoos can take.

Under this two-hit model, Brugge says, one normal copy of BRCA1 ought to be able to carry out DNA repair even when the other ...

Cite this: The Role of Hormonal Therapy ... breast cancer than hormone therapy alone, but clinical data indicate that it might achieve an inferior outcome compared with anti-HER2 therapy plus ...